Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors

被引:0
|
作者
Ahmaditaba, Mohammad Ali [1 ]
Tehrani, Mohammad Hassan Houshdar [1 ]
Zarghi, Afshin [1 ]
Shahosseini, Sorayya [1 ]
Daraei, Bahram [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Chem, Tehran, Iran
[2] Tarbiat Modares Univ, Dept Toxicol, Fac Med Sci, Tehran, Iran
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2018年 / 17卷 / 01期
关键词
Peptide analogue; Solid phase peptide synthesis; Wang resin; COX-2; enzyme; Inhibitor; CYCLOOXYGENASE-2; INHIBITORS; ANTIINFLAMMATORY DRUGS; MECHANISM; IDENTIFICATION; POTENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO2Me or N-3 attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC50 value of 0.08 mu M and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [41] Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy
    Ren, Shen-Zhen
    Wang, Zhong-Chang
    Zhu, Dan
    Zhu, Xiao-Hua
    Shen, Fa-Qian
    Wu, Song-Yu
    Chen, Jin-Jin
    Xu, Chen
    Zhu, Hai-Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 909 - 924
  • [42] Design, synthesis, and biological evaluation of dual-target COX-2/5-LOX inhibitors for the treatment of inflammation
    Du, Le
    Du, Shuaishuai
    Li, Jiaming
    Wang, Hongwei
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (02) : 218 - 238
  • [43] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Luo, C
    He, ML
    Bohlin, L
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
  • [44] Clinical pharmacology of novel selective COX-2 inhibitors
    Tacconelli, S
    Capone, ML
    Patrignani, P
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 589 - 601
  • [45] Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies
    Khatri, Chetan K.
    Indalkar, Krishna S.
    Patil, Chandragouda R.
    Goyal, Sameer N.
    Chaturbhuj, Ganesh U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (08) : 1721 - 1726
  • [46] In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
    Sahu, Ankita
    Pradhan, Dibyabhaba
    Veer, Babita
    Kumar, Sumit
    Singh, Ram
    Raza, Khalid
    Rizvi, Moshahid A. A.
    Jain, Arun Kumar
    Verma, Saurabh
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 31 (02) : 119 - 133
  • [47] Design, synthesis of celecoxib-tolmetin drug hybrids as selective and potent COX-2 inhibitors
    Abdellatif, Khaled R. A.
    Abdelall, Eman K. A.
    Labib, Madlen B.
    Fadaly, Wael A. A.
    Zidan, Taha H.
    BIOORGANIC CHEMISTRY, 2019, 90
  • [48] Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors
    Al-Hourani, Baker Jawabrah
    Sharma, Sai Kiran
    Mane, Jonathan Y.
    Tuszynski, Jack
    Baracos, Vickie
    Kniess, Torsten
    Suresh, Mavanur
    Pietzsch, Jens
    Wuest, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1823 - 1826
  • [49] New paracetamol hybrids as anticancer and COX-2 inhibitors: Synthesis, biological evaluation and docking studies
    Alam, Mohammad Mahboob
    Alsenani, Nawaf I.
    Abdelhamid, Antar A.
    Ahmad, Abrar
    Baothman, Othman A.
    Hosawi, Salman A.
    Altayeb, Hisham
    Nadeem, Mohammad Shahid
    Ahmad, Varish
    Nazreen, Syed
    Elhenawy, Ahmed A.
    ARCHIV DER PHARMAZIE, 2024, 357 (01)
  • [50] DESIGN AND SYNTHESIS OF SUBSTITUTED PYRROLE DERIVATIVES AS COX-2 INHIBITORS
    Kumar, R.
    Subramanian, A.
    Masand, N.
    Patil, V. M.
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2010, 5 (03) : 667 - 674